Insulinoma: Clinical Trials

9 trials for Insulinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 19Completed 9
Phase 21Completed 1

Follow Insulinoma: new trials by email Literature Review of Insulinoma trials Research Report on Insulinoma

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Laser Tissue Welding - Distal Pancreatectomy Sealing Study
Distal Pancreatectomy Sealing Using LTW - Pancreatic Tumor, Benign, Pancreatic Neoplasms
Phase 1CompletedLaser Tissue Welding, Inc.112018-01-012022-04-06
68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH
68Ga-NODAGA-exendin 4 PET/CT - Insulinoma
Phase 1 / Phase 2CompletedRadboud University Medical Center562015-04-012021-06-16
Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma
Cixutumumab, Everolimus, Laboratory Biomarker Analysis - Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor
Phase 1CompletedNational Cancer Institute (NCI)272010-10-012016-07-15
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
everolimus, vatalanib, pharmacological study - Gastrinoma, Glucagonoma
Phase 1CompletedMayo Clinic962004-12-012024-08-21
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
90Y-DOTA-tyr3-OCTREOTIDE - Brain and Central Nervous System Tumors, Gastrointestinal Carcinoid Tumor
Phase 1CompletedO'Dorisio, M S272002-01-012016-06-21
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
trastuzumab, tipifarnib - Cancer
Phase 1CompletedNational Cancer Institute (NCI)242000-06-012013-02-11
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum
floxuridine, leucovorin calcium, oxaliplatin - Cancer
Phase 1CompletedMemorial Sloan Kettering Cancer Center2000-04-012011-04-26
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
recombinant interleukin-12, ABI-007/carboplatin/trastuzumab - Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer
Phase 1CompletedNational Cancer Institute (NCI)151999-08-012013-02-28
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
yttrium Y 90-edotreotide - Brain and Central Nervous System Tumors, Breast Cancer
Phase 1CompletedNovartis Pharmaceuticals601998-01-012013-05-01

Narrower conditions

Glucagonoma (7)  ·  Carcinoma, Islet Cell (6)  ·  Gastrinoma (6)  ·  Somatostatinoma (6)  ·  Vipoma (5)  ·  Carcinoma, Medullary (4)  ·  Carcinoma, Non-Small-Cell Lung (4)  ·  Pancreatic Neoplasms (4)  ·  Adenoma, Islet Cell (3)  ·  Appendiceal Neoplasms (3)  ·  Bile Duct Neoplasms (3)  ·  Breast Neoplasms (3)  ·  Carcinoma, Hepatocellular (3)  ·  Carcinoma, Renal Cell (3)

Broader conditions

Adenoma (9)  ·  Digestive System Diseases (9)  ·  Digestive System Neoplasms (9)  ·  Endocrine Gland Neoplasms (9)  ·  Endocrine System Diseases (9)  ·  Neoplasms by Histologic Type (9)  ·  Neoplasms by Site (9)  ·  Neoplasms, Glandular and Epithelial (9)  ·  Pancreatic Diseases (9)  ·  Adenocarcinoma (8)  ·  Carcinoma (8)  ·  Neoplasms, Germ Cell and Embryonal (8)  ·  Neuroectodermal Tumors (8)  ·  Neuroendocrine Tumors (8)  ·  Carcinoma, Neuroendocrine (7)

Interventions

Everolimus (2)  ·  Trastuzumab (2)  ·  90Y-octreotide, DOTA-Tyr(3)- (1)  ·  Acetates (1)  ·  Floxuridine (1)  ·  High-Energy Shock Waves (1)  ·  Interleukin-12 (1)  ·  Interleukin-12 Subunit p35 (1)  ·  Leucovorin (1)  ·  Octreotide (1)  ·  Oxaliplatin (1)  ·  Salts (1)  ·  cixutumumab (1)  ·  tipifarnib (1)  ·  vatalanib (1)

Sponsors

National Cancer Institute (NCI) (3)  ·  Laser Tissue Welding, Inc. (1)  ·  Mayo Clinic (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Novartis Pharmaceuticals (1)  ·  O'Dorisio, M S (1)  ·  Radboud University Medical Center (1)

Countries

United States (8)

Top investigators

Anthony W. Tolcher, MD (1)  ·  James Yao (1)  ·  Julian R. Molina, M.D., Ph.D. (1)  ·  Larry K. Kvols, MD (1)  ·  Leonard B. Saltz, MD (1)  ·  M. Sue O'Dorisio, MD, PhD (1)  ·  Martin Gotthardt, Prof. Dr. (1)  ·  William Carson (1)

Results publications

PMID 20847174, PMID 25900182

NIH funding

2014 (1), P30CA016672 (1), R44CA203052 (1), U01CA062461 (1), U01CA076576 (1)